Skip to main navigation
Skip to main content
Opthea Limited, Inc Logo
  • Home
  • Corporate Governance
  • Press Releases
  • Events & Presentations
  • Stock Info
    Stock Quote Stock Chart Historical Stock Quote Analysts
  • ASX Filings
  • SEC Filings
  • Reports
  • Resources
    Investor FAQs Investor Email Alerts Contact Us

ASX Filings

Opthea Reports Positive Phase 1/2A Clinical Results
April 3, 2017
Entitlement Offer Cleansing Statement
April 3, 2017
Opthea Launches A$45M Financing for Clinical Development
April 3, 2017
Trading Halt
April 3, 2017
Appendix 3B
April 3, 2017
Opthea Phase 1/2A wet AMD Trial Update Presentation
April 3, 2017
Opthea A$45M Equity Raising Launch Presentation
April 3, 2017
Opthea to Host Update on OPT-302 Phase 1/2A wAMD Trial
March 31, 2017
Trading Halt
March 30, 2017
Opthea Receives EU Regulatory Feedback for OPT-302 Program
March 20, 2017
Pagination
  • First page «
  • Previous page ‹
  • …
  • Page 60
  • Page 61
  • Current page 62
  • Page 63
  • Page 64
  • …
  • Next page ›
  • Last page »
Displaying 611 - 620 of 654

If you wish to receive email alerts on company news, please sign up below:

  • © Opthea Limited, Inc 2024